Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02967692
Title A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma (COMBI-i)
Acronym COMBI-i
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUT | AUS

Facility Status City State Zip Country Details
California Cancer Associates for Research and Excellence SC-2 Encinitas California 92024 United States Details
UC Irvine Medical Center SC Orange California 92868 United States Details
California Pacific Medical Center San Francisco California 94115 United States Details
Stanford Cancer Center SC-2 Stanford California 94305 United States Details
University of Kansas Cancer Center SC Westwood Kansas 66205 United States Details
Johns Hopkins U SC Lutherville Maryland 21093 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
NYU Laura and Isaac Perlmutter Cancer Center SC New York New York 10016 United States Details
University of Pittsburgh Med Center SC Pittsburgh Pennsylvania 15213 United States Details
University of Tennessee Medical Center SC Knoxville Tennessee 37920 United States Details
Univ of TX MD Anderson Cancer Cntr SC 2 Houston Texas 77030 United States Details
Utah Cancer Specialists SC 2 Salt Lake City Utah 84106 United States Details
Novartis Investigative Site Caba Buenos Aires C1125ABD Argentina Details
Novartis Investigative Site Caba Buenos Aires C1426ANZ Argentina Details
Novartis Investigative Site Rosario Santa Fe S2000KZE Argentina Details
Novartis Investigative Site Buenos Aires C1431FWO Argentina Details
Novartis Investigative Site Gateshead New South Wales 2290 Australia Details
Novartis Investigative Site North Sydney New South Wales 2060 Australia Details
Novartis Investigative Site Greenslopes Queensland 4120 Australia Details
Novartis Investigative Site Prahran Victoria 3181 Australia Details
Novartis Investigative Site Nedlands Western Australia 6009 Australia Details
Novartis Investigative Site Innsbruck Tyrol 6020 Austria Details
Novartis Investigative Site Graz 8036 Austria Details
Novartis Investigative Site Linz 4020 Austria Details
Novartis Investigative Site Salzburg A-5020 Austria Details
Novartis Investigative Site St Poelten 3100 Austria Details
Novartis Investigative Site Jette Brussel 1090 Belgium Details
Novartis Investigative Site Bruxelles 1200 Belgium Details
Novartis Investigative Site Curitiba PR 80530 010 Brazil Details
Novartis Investigative Site Porto Alegre RS 90035-003 Brazil Details
Novartis Investigative Site Sao Paulo SP 01246 000 Brazil Details
Novartis Investigative Site Rio de Janeiro 20560-120 Brazil Details
Novartis Investigative Site Plovdiv 4004 Bulgaria Details
Novartis Investigative Site Sofia 1303 Bulgaria Details
Novartis Investigative Site Vancouver British Columbia V5Z 4E6 Canada Details
Novartis Investigative Site Toronto Ontario M4N 3M5 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Montreal Quebec H4A 3J1 Canada Details
Novartis Investigative Site Sherbrooke Quebec J1H 5N4 Canada Details
Novartis Investigative Site Temuco Araucania 4810469 Chile Details
Novartis Investigative Site Santiago 7500921 Chile Details
Novartis Investigative Site Santiago 8420383 Chile Details
Novartis Investigative Site Zlin Czech Republic 762 75 Czechia Details
Novartis Investigative Site Hradec Kralove CZE 500 05 Czechia Details
Novartis Investigative Site Olomouc CZE 779 00 Czechia Details
Novartis Investigative Site Ostrava Poruba 708 52 Czechia Details
Novartis Investigative Site Brno 65653 Czechia Details
Novartis Investigative Site Praha 10 100 34 Czechia Details
Novartis Investigative Site Praha 12808 Czechia Details
Novartis Investigative Site Aarhus 8000 C Denmark Details
Novartis Investigative Site Le Mans Cedex 09 72037 France Details
Novartis Investigative Site Limoges Haute Vienne 87000 France Details
Novartis Investigative Site Amiens 80054 France Details
Novartis Investigative Site Besancon Cedex 25030 France Details
Novartis Investigative Site Bobigny Cedex 93009 France Details
Novartis Investigative Site Bordeaux Cedex 33075 France Details
Novartis Investigative Site Boulogne Billancourt 92104 France Details
Novartis Investigative Site Caen 14033 France Details
Novartis Investigative Site Clermont Ferrand 63003 France Details
Novartis Investigative Site Dijon 21000 France Details
Novartis Investigative Site Grenoble 38043 France Details
Novartis Investigative Site Lille 59037 France Details
Novartis Investigative Site Lorient 56322 France Details
Novartis Investigative Site Lyon 69373 France Details
Novartis Investigative Site Marseille Cedex 05 13885 France Details
Novartis Investigative Site Mulhouse cedex 68070 France Details
Novartis Investigative Site Nice 06202 France Details
Novartis Investigative Site Paris 10 75475 France Details
Novartis Investigative Site Pierre Benite 69495 France Details
Novartis Investigative Site Poitiers 86021 France Details
Novartis Investigative Site Reims 51092 France Details
Novartis Investigative Site Rouen Cedex 76031 France Details
Novartis Investigative Site Strasbourg Cedex 67091 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Vandoeuvre-les-Nancy 54519 France Details
Novartis Investigative Site Villejuif 94800 France Details
Novartis Investigative Site Mannheim Baden Wuerttemberg 68305 Germany Details
Novartis Investigative Site Regensburg Bavaria 93053 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Berlin 13578 Germany Details
Novartis Investigative Site Bonn 53105 Germany Details
Novartis Investigative Site Chemnitz 09117 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Duesseldorf 40225 Germany Details
Novartis Investigative Site Erfurt 99089 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Freiburg 79106 Germany Details
Novartis Investigative Site Gera 07548 Germany Details
Novartis Investigative Site Halle Saale 06120 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Hannover 30625 Germany Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Homburg 66421 Germany Details
Novartis Investigative Site Kiel 24105 Germany Details
Novartis Investigative Site Leipzig 04103 Germany Details
Novartis Investigative Site Mainz 55131 Germany Details
Novartis Investigative Site Marburg 35039 Germany Details
Novartis Investigative Site Minden 32429 Germany Details
Novartis Investigative Site Muenchen 81377 Germany Details
Novartis Investigative Site Muenster 48157 Germany Details
Novartis Investigative Site Stade 21682 Germany Details
Novartis Investigative Site Tuebingen 72076 Germany Details
Novartis Investigative Site Athens 115 27 Greece Details
Novartis Investigative Site Athens 18547 Greece Details
Novartis Investigative Site Budapest H 1122 Hungary Details
Novartis Investigative Site Debrecen 4032 Hungary Details
Novartis Investigative Site Szeged H 6725 Hungary Details
Novartis Investigative Site Haifa 3109601 Israel Details
Novartis Investigative Site Jerusalem 9112001 Israel Details
Novartis Investigative Site Ramat Gan 52621 Israel Details
Novartis Investigative Site Bari BA 70124 Italy Details
Novartis Investigative Site Bergamo BG 24127 Italy Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Brescia BS 25123 Italy Details
Novartis Investigative Site Meldola FC 47014 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Padova PD 35100 Italy Details
Novartis Investigative Site Roma RM 00167 Italy Details
Novartis Investigative Site Siena SI 53100 Italy Details
Novartis Investigative Site Candiolo TO 10060 Italy Details
Novartis Investigative Site Torino TO 10126 Italy Details
Novartis Investigative Site Verona VR 37126 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Kyushu University Hospital Fukuoka city Fukuoka 812-8582 Japan Details
Kyoto University Hospital Sakyo Ku Kyoto 606 8507 Japan Details
Osaka International Cancer Institute Osaka-city Osaka 541-8567 Japan Details
Tokyo Metropolitan Komagome Hospital Bunkyo ku Tokyo 113-8677 Japan Details
National Cancer Hospital Chuo ku Tokyo 104 0045 Japan Details
Novartis Investigative Site Mexico Distrito Federal 14080 Mexico Details
Novartis Investigative Site Leon Guanajuato 37178 Mexico Details
Novartis Investigative Site Guadalajara Jalisco 44100 Mexico Details
Novartis Investigative Site Breda 4819 EV Netherlands Details
Novartis Investigative Site Leiden 2300 RC Netherlands Details
Novartis Investigative Site Oslo 0379 Norway Details
Novartis Investigative Site Gdansk 80 952 Poland Details
Novartis Investigative Site Warszawa 02 781 Poland Details
Novartis Investigative Site Lisboa 1099 023 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Chelyabinsk 454048 Russian Federation Details
Novartis Investigative Site Moscow 115478 Russian Federation Details
Novartis Investigative Site Moscow 143423 Russian Federation Details
Novartis Investigative Site Nizhny Novgorod 603137 Russian Federation Details
Novartis Investigative Site Omsk 644013 Russian Federation Details
Novartis Investigative Site Saint Petersburg 198255 Russian Federation Details
Novartis Investigative Site Samara 443011 Russian Federation Details
Novartis Investigative Site St Petersburg 197758 Russian Federation Details
Novartis Investigative Site Malaga Andalucia 29010 Spain Details
Novartis Investigative Site Sevilla Andalucia 41009 Spain Details
Novartis Investigative Site Oviedo Asturias 33011 Spain Details
Novartis Investigative Site Jerez Cadiz 11407 Spain Details
Novartis Investigative Site Badalona Catalunya 08916 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46014 Spain Details
Novartis Investigative Site La Coruna Galicia 15006 Spain Details
Novartis Investigative Site Las Palmas De Gran Canarias 35016 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Madrid 28222 Spain Details
Novartis Investigative Site Goteborg SE-413 45 Sweden Details
Novartis Investigative Site Lund 221 85 Sweden Details
Novartis Investigative Site Stockholm SE 171 76 Sweden Details
Novartis Investigative Site Aarau 5001 Switzerland Details
Novartis Investigative Site Zuerich 8091 Switzerland Details
Novartis Investigative Site Songkhla Hat Yai 90110 Thailand Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Truro Cornwall TR1 3LJ United Kingdom Details
Novartis Investigative Site Surrey England GU2 7XX United Kingdom Details
Novartis Investigative Site Northwood Middlesex HA6 2RN United Kingdom Details
Novartis Investigative Site Sutton Surrey SM2 5PT United Kingdom Details
Novartis Investigative Site Leicester LE1 5WW United Kingdom Details
Novartis Investigative Site London NW3 2QG United Kingdom Details
Novartis Investigative Site Manchester M20 4BX United Kingdom Details
Novartis Investigative Site Middlesbrough TS4 3BW United Kingdom Details
Novartis Investigative Site Preston PR2 9HT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field